These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 7706435)
1. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells. Koka P; He K; Camerini D; Tran T; Yashar SS; Merrill JE J Neuroimmunol; 1995 Mar; 57(1-2):179-91. PubMed ID: 7706435 [TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. Koka P; He K; Zack JA; Kitchen S; Peacock W; Fried I; Tran T; Yashar SS; Merrill JE J Exp Med; 1995 Oct; 182(4):941-51. PubMed ID: 7561697 [TBL] [Abstract][Full Text] [Related]
3. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Fenouillet E; Miquelis R; Drillien R Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025 [TBL] [Abstract][Full Text] [Related]
4. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain. Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency virus type 1 envelope glycoprotein. Pasquali JL; Kieny MP; Kolbe H; Christmann D; Knapp AM AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1107-13. PubMed ID: 1702300 [TBL] [Abstract][Full Text] [Related]
6. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network. Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820 [TBL] [Abstract][Full Text] [Related]
7. Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells. Travis BM; Dykers TI; Hewgill D; Ledbetter J; Tsu TT; Hu SL; Lewis JB Virology; 1992 Jan; 186(1):313-7. PubMed ID: 1727607 [TBL] [Abstract][Full Text] [Related]
8. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. Abacioglu YH; Fouts TR; Laman JD; Claassen E; Pincus SH; Moore JP; Roby CA; Kamin-Lewis R; Lewis GK AIDS Res Hum Retroviruses; 1994 Apr; 10(4):371-81. PubMed ID: 8068416 [TBL] [Abstract][Full Text] [Related]
9. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells. Rodriguez D; Rodriguez JR; Esteban M AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199 [TBL] [Abstract][Full Text] [Related]
10. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. Earl PL; Broder CC; Long D; Lee SA; Peterson J; Chakrabarti S; Doms RW; Moss B J Virol; 1994 May; 68(5):3015-26. PubMed ID: 7512157 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates. Nakamura GR; Byrn R; Rosenthal K; Porter JP; Hobbs MR; Riddle L; Eastman DJ; Dowbenko D; Gregory T; Fendly BM AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1875-85. PubMed ID: 1283308 [TBL] [Abstract][Full Text] [Related]
12. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. Poumbourios P; el Ahmar W; McPhee DA; Kemp BE J Virol; 1995 Feb; 69(2):1209-18. PubMed ID: 7815497 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. Maciejewski JP; Weichold FF; Young NS J Immunol; 1994 Nov; 153(9):4303-10. PubMed ID: 7523521 [TBL] [Abstract][Full Text] [Related]
14. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. Fenouillet E; Jones IM J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780 [TBL] [Abstract][Full Text] [Related]
15. Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41. Chirmule N; Kalyanaraman VS; Saxinger C; Wong-Staal F; Ghrayeb J; Pahwa S AIDS Res Hum Retroviruses; 1990 Mar; 6(3):299-305. PubMed ID: 2187499 [TBL] [Abstract][Full Text] [Related]
16. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques. Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685 [TBL] [Abstract][Full Text] [Related]
17. Role of HIV-1 envelope V3 loop cleavage in cell tropism. Gu R; Westervelt P; Ratner L AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475 [TBL] [Abstract][Full Text] [Related]
18. [HIV-1 env glycoprotein gp120 and gp160 expressed in vaccinia virus system and their antigenicity analysis]. Chen Y; Garcia R; Baralle FE Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):120-6. PubMed ID: 10453506 [TBL] [Abstract][Full Text] [Related]
19. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation. Berman PW; Nakamura GR AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519 [TBL] [Abstract][Full Text] [Related]
20. Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion. Dash B; McIntosh A; Barrett W; Daniels R J Gen Virol; 1994 Jun; 75 ( Pt 6)():1389-97. PubMed ID: 8207403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]